MediPharm Labs (TSE:LABS) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MediPharm Labs announces the departure of President and Co-Founder Keith Strachan, who will transition to a role on the Board of Directors. Under Strachan’s leadership, the company made significant strides, including becoming the first commercial cannabis company in Canada to receive GMP site registration from the US FDA. MediPharm remains focused on international growth and maintaining a strong financial position.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.

